Robyn Karnauskas at Deutsche Bank wrote in a note to investors that the label change was mostly expected and investors already expect a decline in Epogen use.
Still more franchises are elevating from within rather than gearing up to bid for big-name and high-priced talent: with Minnesota taking the interim label off Leslie Frazier on Monday and Dallas expected to do the same with Jason Garrett, as soon as it can complete Rooney Rule obligations in interviewing a minority candidate.